Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Center for International Blood and Marrow Transplant Research
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Takeda
Center for International Blood and Marrow Transplant Research
University of Washington
Memorial Sloan Kettering Cancer Center
Jonsson Comprehensive Cancer Center
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Groupe Francophone des Myelodysplasies
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
Cogent Biosciences, Inc.
M.D. Anderson Cancer Center
Disc Medicine, Inc
University of Washington
Chengdu Zenitar Biomedical Technology Co., Ltd
Peking University People's Hospital
Emory University
Fred Hutchinson Cancer Center
Case Comprehensive Cancer Center
Mayo Clinic
Orca Biosystems, Inc.
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center